Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - INTEREST INCOME & EXPENSE
Interest Income & Expense ALNY - Alnylam Pharmaceuticals, Inc.
142 M
LAST VALUE
-4.63%
2 YEAR CAGR
0.00%
5 YEAR CAGR
49.41%
10 YEAR CAGR